HomeInsightsResults

Glaxosmithkline Pharmaceuticals Ltd Quarterly Result

Glaxosmithkline Pharmaceuticals Ltd Quarterly Result

stocks purchased

₹ 0.3 Cr

Volume Transacted

(Dec 27, 2024)

stocks purchased

1.3 K

Stocks Traded

(Dec 27, 2024)

Last Updated on: Dec 28, 2024

Image

Glaxosmithkline Pharmaceuticals Ltd

NSE: GLAXO

Net Profit

₹ 252.5

Last updated on: Dec 28, 2024

Key Highlights

  • The revenue of Glaxosmithkline Pharmaceuticals Ltd for the Sep '24 is ₹ 1050 crore as compare to the Jun '24 revenue of ₹ 850.29 crore. This represent the growth of 23.487284%.
  • The ebitda of Glaxosmithkline Pharmaceuticals Ltd for the Sep '24 is ₹ 360.94 crore as compare to the Jun '24 ebitda of ₹ 266.18 crore. This represent the growth of 35.599976%.
  • The net profit of Glaxosmithkline Pharmaceuticals Ltd for the Sep '24 is ₹ 252.5 crore as compare to the Jun '24 net profit of ₹ 182.33 crore. This represent the growth of 38.485165%.

Results Analysis

Market Price of Glaxosmithkline Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Glaxosmithkline Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
27 Dec 20242271.05
26 Dec 20242241.8
24 Dec 20242265.1
23 Dec 20242282.85
20 Dec 20242284.5
19 Dec 20242325.25
18 Dec 20242334.95
17 Dec 20242264.65
16 Dec 20242278.95
13 Dec 20242254.45

Historical Revenue of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in crore

Glaxosmithkline Pharmaceuticals Ltd News Hub

News

GSK Pharma gains as Q2 PAT rises 15% YoY to Rs 249 cr

Profit before exceptional item and tax was at Rs 338.70 crore in the September 2024 quarte...

Read more

30 Oct 2024 10:39

News

Board of GlaxoSmithKline Pharmaceuticals recommends Special Interim Dividend

GlaxoSmithKline Pharmaceuticals announced that the Board of Directors of the Company at it...

Read more

29 Oct 2024 16:10

News

GlaxoSmithKline Pharmaceuticals to declare Quarterly Result

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Compa...

Read more

25 Oct 2024 10:38

News

GSK Pharma Q1 PAT climbs 39% YoY to Rs 182 crore

Revenue from operations grew by 9.89% year on year (YoY) to Rs 811 crore during the quarte...

Read more

03 Aug 2024 12:25

News

GlaxoSmithKline Pharmaceuticals to convene board meeting

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Compa...

Read more

18 Jul 2024 10:38

News

Glaxosmithkline Pharmaceuticals announces change in senior management

Glaxosmithkline Pharmaceuticals announced that Dr. Shalini Menon has been appointed as Exe...

Read more

05 Jul 2024 13:26

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

May 2024

Transcript

Mar 2023

Transcript

Aug 2021

PPT

Feb 2020

PPT

FAQs for Quarterly Results of Glaxosmithkline Pharmaceuticals Ltd

What key financial metrics are included in Glaxosmithkline Pharmaceuticals Ltd's quarterly results?

Key financial metrics in Glaxosmithkline Pharmaceuticals Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Glaxosmithkline Pharmaceuticals Ltd announce its quarterly results?

Glaxosmithkline Pharmaceuticals Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Glaxosmithkline Pharmaceuticals Ltd's quarterly performance impact its stock price?

Glaxosmithkline Pharmaceuticals Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Glaxosmithkline Pharmaceuticals Ltd's quarterly results on dividends?

The impact of Glaxosmithkline Pharmaceuticals Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Glaxosmithkline Pharmaceuticals Ltd's quarterly results?

Yes, Glaxosmithkline Pharmaceuticals Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions